On this page, you will find current research and news relating to genomics and genomic testing: explore here if you are interested in new research or advances in the area of genomics.
In a continent like Australia with its vast remote regions you might expect that access to genomic testing was highest in major cities with large hospitals and other health services.
And you’d be right. But an Australian Genomics study looking at the unmet needs of genomic testing also found that on a per capita basis the rate of testing was higher in some “remote” areas compared with major cities.
A ground-breaking study into government-funded genetic carrier screening for Australian couples seeking to have children has published its main findings in the leading international journal, The New England Journal of Medicine.
A new interactive online consent tool developed by Australian Genomics provides easy and accessible information in bite-sized chunks to guide patients through the key concepts of genomic testing.
A study on Australians and their views on involvement in health and medical research show that more than 60% of Australians believe research should be informed by community views and would like their voices heard.
A suite of materials in multiple languages, now openly available, has been developed to enable better understanding of genetics and genomics among Australia’s culturally and linguistically diverse communities.
A new Australian Genomics study centred on Tasmania sheds light on the diagnostic pathways for rare diseases in regional Australia and recommends actions to overcome some of the barriers, including the establishment of a Rare Care Centre.
The Science Within Us program by GSNV addresses the need for current, evidence-based genomic information in schools by providing comprehensive, age-appropriate genomics education for students aged 10 to 18.
Involve Australia asks funders to require community involvement in all grant opportunities in recently published recommendations for health and medical research funders and institutes.
How do you measure the value of a genomic test? It depends who you are, of course. While providing a diagnosis might be paramount for a patient, for a clinician it might be managing the condition. And for a government department it might be cost savings.
